2 , 3 1' 0 .5 %$ 4 0' (& 2 77 1) %$!2 · 2020. 3. 31. · 1 }Ó y ) ( Ó ªª%Ë 98gvgw@xOtx þpreproinsulin ÿ V Ý@ xOtx) b 8/%) 8 ¥ Ä û< 8 õ s)3" ( Ó º þ \ ÿå tajp

$Page 1: 2 , 3 1' 0 .5 %$ 4 0' (& 2 77 1*) %$!2 · 2020. 3. 31. · 1 }*Ó y ) ( Ó ªª%Ë 98gvgw@xOtx þpreproinsulin ÿ V Ý*@ xOtx) b 8/%) 8 ¥ Ä û< 8 õ s)3" ( Ó º þ \ ÿå ta*jp$
2 1 0

2

�

�

1

1

0

0

1

1

�

preproinsulin

3

a

10% a

b 10%

a b null

(1) a b

(2) (1)

�

2

1

2

�

!∗ !

!∗ = ∑ #!(#!%&)"!#$∑ #!"!#$

#( $ %!

! = ∑ #()(*&%

X 16

!∗ ! ! !∗

1 0 1 0 0 2 0 0 0 0 1 1

4 0 0 2 3 2 0 2 0 4 2 3

0 6 7 4 0 5 0 1 6 0 2 0

0 0 6 1 1 0 0 0 0 0 5 0

! !∗

!∗ = ( + *!

( !∗ *

( = 0, * = 1 ( = 0, * > 1 ( = −1, * ≈ 1

X

3

( *X

�

1

3

(A) Tyr

(B) Ser/Thr

(C)

(A) (C)

2

4

� 1 2

1 1 7

(a) (c)

DNA

1 1

DNA

1 2 DNA

1 3

DNA 4

5 1 DNA

DNA

6 DNA 6 DNA

DNA 7

(a) 100 (b) 5000 (c) 30000

2 1 3

1 3

1

2

3

5

1

2 3 2 1

2 10

1 2

3

6

.

()

()

� 1 2

,

1 , , ,

,

( )

2n

n 0.75 0.5

1

1 A, B, C

7

�! 8�!9

or or

or

�1 �;8 �9 C:��8��9

A:�:8��9 B:�;8�9

0.75

0.51

(B)�! 8�!9

or or

or

�1 �;8 �9

(A)

�: ��$1��+15274637"+��(A)*��8B9.��#�,�!&.-(�*�:&.-(�8��90 ')%/

C:��8��9

A:�:8��9 B:�;8�9

� 1 4

(A)mRNA

X X

(B) X

(C) X (D)

1 A mRNA

2 B

1

3 C X

4 D

X

8

�

150

9

1 2

Mottenohoka

XX

1 Mottenohoka X PCR1 X

PCRA B C D E F

2 10PCR PCR

3 X

10

10 1 3

ABC 4

1

ABC

ABC

1 1 ABC

2 ABC

1

11

3 1

(1)

(2)

Documents

2 , 3 1' 0 .5 %$ 4 0' (& 2 77 1*) %$!2 · 2020. 3. 31. · 1 }*Ó y ) ( Ó ªª%Ë 98gvgw@xOtx þpreproinsulin ÿ V Ý*@ xOtx) b 8/%) 8 ¥ Ä û< 8 õ s)3" ( Ó º þ \ ÿå ta*jp

2 , 3 1' 0 .5 %$ 4 0' (& 2 77 1) %$!2 · 2020. 3. 31. · 1 }Ó y ) ( Ó ªª%Ë 98gvgw@xOtx þpreproinsulin ÿ V Ý@ xOtx) b 8/%) 8 ¥ Ä û< 8 õ s)3" ( Ó º þ \ ÿå tajp